Several identified genetic and/or transcriptional indicators including IDH mutation, O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion were found to be closely related to glioma prognosis 30. Here, MGMT is linked to central nervous system cancer.